GRIMES & COMPANY, INC. – BioCryst Pharmaceuticals, Inc. Transaction History
GRIMES & COMPANY, INC. portfolio value:
$907,000
portfolio value
GRIMES & COMPANY, INC. quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.34% | 948 shares | 156K | $12.6 | 71.94K |
| Q2 2022 | share | Increase | +3.25% | 2.23K shares | -367K | $10.58 | 70.99K |
| Q1 2022 | share | Increase | +5.02% | 3.28K shares | 211K | $16.26 | 68.76K |
| Q4 2021 | share | Increase | +24.30% | 12.80K shares | 150K | $13.79 | 65.47K |
| Q3 2021 | share | Increase | +4.08% | 2.06K shares | -43K | $14.37 | 52.67K |
| Q2 2021 | share | Decrease | -2.24% | -1.15K shares | 274K | $15.81 | 50.60K |
| Q1 2021 | share | Increase | +43.98% | 15.81K shares | 258K | $10.17 | 51.76K |
| Q4 2020 | share | Increase | +139.67% | 20.95K shares | 216K | $7.45 | 35.95K |
| Q3 2020 | share | Increase | 0.00% | 15K shares | 52K | $3.44 | 15K |